NCT07270601
- Conditions
- Digestive System Diseases, Fatty Liver, Fibrosis, +6 more
- Locations
-
- University of Washington Seattle, Washington, United States
Clinical trial condition
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Explore clinical trials studying MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease. Study availability and eligibility vary by location and protocol.
33 public trials
16 recruiting studies
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease trial results
NCT07091539
- Conditions
- Food Insecurity Among Children, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT07090083
- Conditions
- Food Insecurity, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT07093346
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +11 more
- Locations
-
- Sir Peter Mansfield Imaging Centre, University of Nottingham Nottingham, United Kingdom
- Nottingham Clinical Research Facility at Nottingham University Hospitals NHS Trust Nottingham, United Kingdom
- University of Nottingham Nottingham, United Kingdom
NCT04873258
- Conditions
- Body Weight, Digestive System Diseases, Fatty Liver, +12 more
- Locations
-
- Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge London, United Kingdom
NCT06386094
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiac Disease, +12 more
- Locations
-
- Dr. Madhumita Premkumar Chandigarh, India
Enrolling by Invitation
Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)
NCT06845345
- Conditions
- Behavior, Body Weight, Cardio-metabolic Health, +35 more
- Locations
-
- Franciscus Rotterdam, Netherlands
Enrolling by Invitation
Assessment of Non-Invasive Testing in Major Liver-Related Outcomes
NCT06986447
- Conditions
- MASLD, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), +2 more
- Locations
-
- Arizona Liver Health Chandler, Arizona, United States
- Arizona Liver Health Peoria, Arizona, United States
- Arizona Liver Health Tucson, Arizona, United States
- CRIOH Westlake, Ohio, United States
Enrolling by Invitation
MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study
NCT07312136
- Conditions
- Advanced Fibrosis, Apnea, Atrophy, +39 more
- Locations
-
- Department of Gastroenterology and Hepatology, Linköping University Hospital Linköping, Östergötland County, Sweden
Not Yet Recruiting
Duodenal pulsENDO for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease
NCT07390422
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +9 more
- Locations
-
- Chinese University of Hong Kong Shatin, Hong Kong